Table 3.

The outcome of CML patients with COVID-19 and control group.

	CML	Control Group	P value
ICU admission, n (%)	1 (%6,3)	11 (22,9%)	0,1
MV, n (%)	1 (%6,3)	10 (20,8%)	0,2
Duration in hospital, days	9 (2–18)	18 (4–46)	0,8
CFR, n (%)	1 (6,3%)	6 (12,8%)	0,5

CFR: case fatality rate; CML: chronic myeloid leukemia; ICU: intensive care unit; MV: mechanical ventilation.